InvestorsHub Logo
icon url

Hansm7777

08/02/19 8:59 AM

#238240 RE: marzan #238238

It's all going to come out in the wash. His numbers (projections, extrapolations and of course his calculated estimates) will now be questioned over and over by his medical peers. He will have to defend every line of data that he presented to the FDA. There'll be no place for him to hide. I think we may now understand the action behind the NVCR CEO selling 190,338 shares on 06/18 and 47,271 shares on 06/12 (only 8 days after ASCO ended). Hmmmmmm. Just keeps getting better and better. IMHO